| Pharmaceutical active ingredients: |
| Sodium Polystyrene Sulfonate |
| Available forms, composition and doses of Resonium A: |
| Powder; Oral; Sodium Polystyrene Sulfonate 99.934% |
| Resonium A medical category: |
| Human:Potassium-removing agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AE01 - Polystyrene Sulfonate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisIDS GroupIrex Laboratoires |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Resolve Plus | Hydrocortisone; Miconazole Nitrate | Ego Pharmaceuticals |
| Resolve Thrush | Miconazole Nitrate | Ego Pharmaceuticals; Zuellig Pharma |
| Resolve Tinea Cream | Miconazole Nitrate; Phenylethyl Alcohol | Ego Pharmaceuticals; Zuellig Pharma |
| Resolve Tinea Powder | Miconazole Nitrate; Zinc Oxide | Ego Pharmaceuticals; Zuellig Pharma |
| Resonium | Sodium Polystyrene Sulfonate | Sanofi-Aventis; Irex Laboratoires |
| Resonium Calcium | Calcium Polystyrene Sulfonate | Sanofi-Aventis |
| Resoquina | Chloroquine | Unidentified Pharmaceutical Company |
| Resoquine | Chloroquine | Unidentified Pharmaceutical Company |
| Re-Sorb Oral Hydration | Citric Acid; Dextrose; Glycine; Potassium Citrate; Potassium Phosphate Dibasic; Sodium Chloride | GlaxoSmithKline |
| Resorba | Zoledronic Acid Monohydrate | Pharm Sintez |